Daiichi Sankyo
Harry H. Suiter is a seasoned professional with extensive experience in global project management and leadership, particularly in the oncology sector. Currently serving as Senior Director at Daiichi Sankyo, Inc. since May 2020, Harry previously held various roles at Merck from March 2016 to April 2020, culminating in the position of Associate Director of Oncology Project Management. Other notable positions include Senior Consultant at Susan B. Levy Consulting and Director of Project Management at Merck Consumer Care. Harry's career began at Quantitative Technologies, Inc., and spans multiple companies with increasing responsibilities in project and program management within the pharmaceutical and consumer health industries. Harry holds a BA in Chemistry from Rutgers University and an MBA in Marketing from the University of Phoenix.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.